Gemcitabine in combination with paclitaxel for advanced soft-tissue sarcomas.

Sonnenblick, Amir; Eleyan, Feras; Peretz, Tamar; Ospovat, Inna; Merimsky, Ofer; Sella, Tamar; Peylan-Ramu, Nili; Katz, Daniela

Sonnenblick, Amir; Eleyan, Feras; Peretz, Tamar; Ospovat, Inna; Merimsky, Ofer; Sella, Tamar; Peylan-Ramu, Nili; Katz, Daniela.

Afiliación

Sonnenblick A; Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel.
Eleyan F; Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel.
Peretz T; Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel.
Ospovat I; Department of Oncology, The Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Ramat Aviv 69978, Israel.
Merimsky O; Department of Oncology, The Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Ramat Aviv 69978, Israel.
Sella T; Department of Radiology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel.
Peylan-Ramu N; Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel.
Katz D; Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel.

Mol Clin Oncol ; 3(4): 829-832, 2015 Jul.

Article en En | MEDLINE | ID: mdl-26171190

Palabras clave

gemcitabine; paclitaxel; soft-tissue sarcomas; stage 4

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: Mol Clin Oncol Año: 2015 Tipo del documento: Article País de afiliación: Israel

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google